{
    "nctId": "NCT06438055",
    "briefTitle": "Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results",
    "officialTitle": "Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Refractory Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Objective Response Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female, aged \u2265 18 years and \u2264 75 years old;\n2. Breast cancer confirmed by histology or cytology;\n3. One of the following two conditions shall be met: a) Operable breast cancer: Recurrent progression during adjuvant therapy; or the time from initial treatment to the onset of disease progression is less than or equal to 2 years; b) Non-operable breast cancer: patients who have changed two line treatment plans within 6 months;\n4. Being able to obtain sufficient fresh tissue specimens for organoid establishment through puncture;\n5. Expected survival time \u2265 3 months;\n6. The patient voluntarily joined this study and signed an informed consent form (ICF), with good compliance and cooperation in follow-up.\n\nExclusion Criteria:\n\n1. Pregnant and lactating women;\n2. Patients who have clinically significant (i.e. active) heart disease (such as congestive heart failure, symptomatic coronary artery disease, arrhythmia, etc.) or myocardial infarction within the past 12 months;\n3. Individuals with a history of abuse of psychotropic drugs who are unable to quit or have mental disorders;\n4. The researchers believe that patients are not suitable for inclusion.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}